Britain secures 60 mln doses of Sanofi/GSK coronavirus vaccine
Sanofi and GSK confirmed in a statement that regulatory approval for their vaccine could be achieved by the first half of 2021 if clinical data was positive.
A laboratory technician is seen at the Inselspital Universitaetsspital Bern university hospital during researches for a vaccine against the coronavirus disease (COVID-19) in Bern, Switzerland April 22, 2020(photo credit: REUTERS)ByREUTERS
